News Clip5:07
Bloomberg

Kamala Harris Receives First Dose of Covid-19 Vaccine

Higher Ed
Dec.29 -- Vice President-elect Kamala Harris receives her first dose of Moderna's Covid-19 vaccine at United Medical Center in Southeast Washington, D.C.
News Clip11:32
Bloomberg

Bond Market Needs to Be Overhauled, Says Guggenheim's Millstein

Higher Ed
Jan.26 -- Guggenheim Securities Co-Chairman Jim Millstein says debt markets should be revamped after the Federal Reserve came to their rescue. He speaks on "Bloomberg Markets."
News Clip6:53
Bloomberg

South Africa ‘on Course’ With Economy: Standard Bank’s Fuzile

Higher Ed
Nov.19 -- Lungisa Fuzile, South Africa chief executive officer at Standard Bank, discusses South Africa’s sovereign debt, the economy and fighting corruption. He speaks on “Bloomberg Daybreak: Europe.”
News Clip4:26
Bloomberg

AstraZeneca Vaccine Trial Likely Needs a Restart: Johns Hopkins

Higher Ed
Nov.27 -- Johns Hopkins Bloomberg School of Public Health Professor and Virologist Andrew Pekosz discusses confusion over the AstraZeneca Covid-19 vaccine trial and the rising number of hospitalizations in Europe. He speaks with...
News Clip5:37
Bloomberg

IMF Says Biden Stimulus Plan Could Boost GDP by 5% Over Three Years

Higher Ed
Jan.26 -- President Joe Biden’s proposal for a $1.9 trillion stimulus plan could boost U.S. output by 1.25% this year and 5% over three years, Gita Gopinath, the chief economist of the International Monetary Fund, said on "Bloomberg the...
News Clip0:53
Curated Video

Global COVID Cases Grow Despite Vaccine Efforts

Higher Ed
The director of the CDC said the U.S. is still in a complicated stage of the pandemic.
News Clip7:01
Bloomberg

Ryan Air's O'Leary on Europe's Return to Travel

Higher Ed
May.18 -- Ryan Air CEO, Michael O'Leary, discusses how European air travel bookings are rising and lays out an optimistic outlook for the Summer months. He speaks with Manus Cranny and Annmarie Hordern on "Bloomberg Daybreak: Europe."
News Clip4:52
Bloomberg

Variants Don’t Pose Great Risk to Vaccinated: Johns Hopkins

Higher Ed
May.21 -- Johns Hopkins Professor of Infectious Diseases Stuart Ray discusses progress made in understanding Covid-19 and concerns about variants. The Bloomberg School of Public Health is supported by Michael R. Bloomberg, founder and...
News Clip4:31
Curated Video

W.H.O. Declares Monkeypox A Global Emergency

Higher Ed
New York City is the current epicenter of the monkeypox outbreak in the U.S., with 778 cases.
News Clip2:53
Press Association

Sajid Javid continues 'Road to Recovery' tour

Higher Ed
Secretary of State for Health Sajid Javid speaks to the media following a visit at the UK Health Security Agency (UKHSA) in a secure facility at Porton Down.
News Clip7:42
Bloomberg

Lilly Aims to Produce 100K Covid-19 Antibody Doses by Year End: CFO

Higher Ed
Jul.30 -- Eli Lilly Chief Financial Officer Joshua Smiley says the drugmaker expects to start registratrion trials of its coronavirus antibody treatment "within the next few weeks" and to produce 100,000 doses of a successful therapeutic...
News Clip3:05
Bloomberg

Covid Vaccines Developing at Record Speeds, Says Duke's Wosinska

Higher Ed
Oct.29 -- Marta Wosinska, deputy director of policy at the Duke-Margolis Center for Health Policy, says vaccines are developing at record speeds, but people need to follow directions to keep safe from Covid. She speaks on "Bloomberg...
News Clip2:19
Bloomberg

Fauci: Pulling Back on Mask Requirements Risky Right Now

Higher Ed
Dr. Anthony Fauci, the top medical adviser to U.S. President Joe Biden, says it is risky to pull back on anti-pandemic measures right now but the number of Covid-19 cases and hospitalizations are trending in the right direction. He...
News Clip4:03
Curated Video

COVID-19 Long-Haulers Face Uncertainty Even With More Research

Higher Ed
Congress has pledged $1.15 billion over four years to study long-haul COVID, but researchers say answers are hard to find.
News Clip0:19
Bloomberg

I Know the Covid Testing Situation Is Frustrating: Biden

Higher Ed
President Joe Biden said long lines for Covid-19 tests -- fueled by surging cases of the omicron variant -- should start to ease as the federal government increases capacity. Biden told reporters at the White House on Tuesday that U.S....
News Clip4:27
Bloomberg

Hong Kong Covid Cases Top 2,000, Set to Double Again

Higher Ed
New Covid-19 cases in Hong Kong have topped 2,000 for the first time. And with another 4,500 preliminary cases on Monday, the tally is set to double yet again. The numbers are overwhelming the city's health-care system, further...
News Clip4:49
AFP News Agency

CLEAN : 'We should have a choice': anti-vaccine protesters march against Covid mandates in DC

9th - Higher Ed
People shouldn't be forced to do these things. We should have a choice," says protester Roger Miller, as he takes part with thousands of demonstrators across the US to a march in Washington, DC, to decry Covid-19 mandates (Footage by...
News Clip6:34
Bloomberg

Epidemiologist Nancy Baxter New Virus Subtype

Higher Ed
Nancy Baxter, Head of Melbourne School of Population and Global Health at The University of Melbourne, discusses the new subtype of the omicron variant as well as China and Hong Kong fight to try combat its worst outbreak of Covid. She...
News Clip3:03
Bloomberg

Johnson & Johnson Begins Study of One-Dose Covid Shot

Higher Ed
Sep.23 -- Johnson & Johnson has begun dosing up to 60,000 volunteers in a study of its Covid-19 vaccine, marking the first big U.S. trial of an inoculation that may work after just one shot. Bloomberg's Robert Langreth reports on...
News Clip3:24
Bloomberg

Mayo Clinic: Likely that Two-Dose Covid-19 Vaccine Will Be Needed

Higher Ed
Jul.20 -- Mayo Clinic Vaccine Research Group Director Gregory Poland discusses the timeline for developing a Covid-19 vaccine and the supplies necessary to effectively distribute the immunizations on "Bloomberg Markets: European Close."
News Clip1:10
Bloomberg

AstraZeneca Vaccine Trial Halted After Spinal-Cord Issue

Higher Ed
Sep.09 -- National Institutes of Health Director Francis Collins says AstraZeneca Plc’s closely watched Covid-19 vaccine trial had been halted due to a "spinal cord problem." He speaks at a congressional hearing . (Excerpt)
News Clip2:39
Sky News

Sir Patrick Vallance Covid Presser Part 2

Higher Ed
CLEAN: Interior shots of Sir Patrick Vallance, Government Chief Scientific Adviser ( GCSA ), speaking at government covid update press conference on 9 September 2020 in London, United Kingdom.
News Clip6:54
Bloomberg

Burger King Parent Working on Reopening Dining Rooms, CEO Says

Higher Ed
May.19 -- Jose Cil, chief executive officer of Burger King's parent company Restaurant Brands International Inc., says the Trump administration was receptive to his request for an extension of the deadline to use small business loan...
News Clip3:33
Curated Video

US vaccine critics protest bill removing exemptions

Higher Ed
Amid a measles outbreak that has sickened more than 50 people in the Pacific Northwest, Washington lawmakers heard testimony Friday on a bill that would remove parents' ability to claim a personal or philosophical exemption to opt their...